Shirai Maki | Worldwide Safety Sciences, PGRD Nagoya Laboratories, Pfizer Inc.
スポンサーリンク
概要
Worldwide Safety Sciences, PGRD Nagoya Laboratories, Pfizer Inc. | 論文
- Introduction of the in vivo Mini-tox study as an effective tool to improve confidence in safety in the early stage of drug development (2) Effects of atypical antipsychotics X(Test methods, Proceedings of the 32nd Annual Meeting)
- O-06 INTRODUCTION OF THE IN VIVO MINI-TOX STUDY AS AN EFFECTIVE TOOL TO IMPROVE CONFIDENCE IN SAFETY IN THE EARLY STAGE OF DRUG DEVELOPMENT(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual